Table 2.
Study | Markers studied | No.* | Positive Markers |
---|---|---|---|
Cools et al., [14] (2005) | PLAP, OCT3/4, CD117, | 15 | PLAP, OCT3/4, CD 117: 1 (>12 yr) |
Hannema et al., [3] (2006) | PLAP, AP2γ | 23 | PLAP, AP2γ: 6 (4 < 12 yr) |
Cheikhelar et al., [15] (2008) | PLAP, CD 117 | 1 | PLAP, CD 117: 1 (>12 yr) |
Wünsch et al., [19] (2012) | PLAP, CD 117, KI 67 | 7 | 0 |
Chaudhry et al., [5] (2017) | PLAP, CD 117, OCT3/4, vimentin | 9 | PLAP: 6 (2<12 yr); CD 117: 3 (2<12 yr); OCT3/4: 1 (1<12 yr); Vimentin: 1 (>12 yr) |
Number of patients submitted to immunohistochemical staining.